# Title

 Food and Drugs. PART 16—REGULATORY HEARING BEFORE THE FOOD AND DRUG ADMINISTRATION


# ID

 CFR-2018-title21-vol1.Pt. 16


# Structured Analysis Summary

| Type        | Values                                                                        |
|:------------|:------------------------------------------------------------------------------|
| Constraints | ['within', 'at least', 'less than', 'before', 'after']                        |
| Duration    | ['1.0 day']                                                                   |
| Condition   | ['not subject to', 'unless', 'where', 'subject to', 'when', 'if']             |
| Entities    | ['Scope', 'Reconsideration', 'Food', 'Denial', 'Inapplicability', 'Judicial'] |


# Structured Analysis With Context

 


## Constraints

| Constraints   | Context                                                                                               |
|:--------------|:------------------------------------------------------------------------------------------------------|
| before        | 16—REGULATORY HEARING BEFORE THE FOOD AND DRUG ADMINISTRATION. before                                 |
| before        | for a regulatory hearing to obtain additional information before  making a decision or taking action. |
| before        | (1) Informal presentation of views  before reporting a criminal violation under section 305 of        |
| within        | by this part; and (4) State the time within which a hearing may be requested, and state               |
| less than     | specified in the notice, which may not be less than 3 working days after receipt of the notice,       |
| after         | may not be less than 3 working days after receipt of the notice, within which to request              |
| within        | 3 working days after receipt of the notice, within  which to request a hearing.                       |
| within        | If no response is filed  within that time, the offer is deemed to have                                |
| less than     | be required to be held at a time less than 2 working days after receipt of the request                |
| after         | at a time less than 2 working days after  receipt of the request for hearing.                         |
| before        | hearing in support of the decision or action. before                                                  |
| at least      | the party requesting the hearing will, if feasible, at least 1 day before the hearing provide to each |
| before        | hearing will, if feasible, at least 1 day before the hearing provide to each other written notice     |
| after         | not receive the notice or copy additional time after the close of the hearing to make a               |
| after         | and substantial issue of fact respecting that issue. after                                            |
| after         | to the presiding officer at the hearing or after  if specifically permitted by the presiding officer. |
| after         | stay of the decision or action under &#167;&#8201;10.35. after                                        |


## Duration

| Duration   | Context                                                                                                                                                                                                                                 |
|:-----------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 1.0 day    | (g) FDA and the party requesting the hearing will, if feasible, at least 1 day before the hearing provide to each other written notice of any published articles or written information to be presented at or relied on at the hearing. |


## Condition

| Condition      | Context                                                                                                                          |
|:---------------|:---------------------------------------------------------------------------------------------------------------------------------|
| if             | person with an opportunity for hearing and spec if ies some procedures for the hearing but not                                   |
| if             | hearing, the FDA, and the presiding officer or, if agreement cannot be reached, at a reasonable time                             |
| if             | hearing, the FDA, and the presiding officer or, if agreement cannot be reached, at a reasonable time                             |
| unless         | administrative action, including enforcement action by the agency unless the Commissioner, as a matter of discretion, determines |
| subject to     | in the same manner as other regulatory hearings subject to  the additional procedures in this section.                           |
| where          | is necessary to protect the public health, except where  expressly prohibited by statute or regulation.                          |
| if             | FDA and the party requesting the hearing will, if feasible, at least 1 day before the hearing                                    |
| if             | A copy will also be provided in advance  if the other participant could not reasonably be expected                               |
| if             | copy is not provided, the presiding officer may, if time permits, allow the party who did not                                    |
| if             | may be denied, in whole or in part, if the Commissioner or the FDA official to whom                                              |
| if             | summary decision on any issue in the hearing if the presiding officer determines from the material submitted                     |
| if             | prior participation, the Commissioner or the delegate should, if feasible, designate a presiding officer for the hearing         |
| if             | Thus,  if the Commissioner's authority to make a final decision                                                                  |
| not subject to | (a) Regulatory hearings are  not subject to  the separation of functions rules in &#167;&#8201;10.55.                            |
| if             | presiding officer or the Commissioner or their advisors if the communication is inconsistent with the requirement of             |
| when           | (a) A regulatory hearing is public, except  when the Commissioner determines that all or part of                                 |
| if             | matter of the proceeding are entitled to attend. if                                                                              |
| subject to     | and an employee or consultant or other person subject to a commercial arrangement as defined in &#167;&#8201;20.81(a) and        |
| unless         | a recommended decision, with a statement of reasons, unless  the Commissioner directs otherwise.                                 |
| if             | the presiding officer at the hearing or after if  spec                                                                           |
| unless         | and views, at the close of the hearing, unless the presiding officer specifically permits additional time for                    |
| if             | consider the administrative record of the hearing spec if ied in &#167;&#8201;16.80(a) together with all other relevant          |


## Entities

| Entities        | Context                                     |
|:----------------|:--------------------------------------------|
| Food            | Food  and Drugs.                            |
| Scope           | Scope .                                     |
| Inapplicability | Inapplicability  and limited applicability. |
| Denial          | Denial  of hearing and summary decision.    |
| Reconsideration | Reconsideration  and stay of action.        |
| Judicial        | Judicial  review.                           |


